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Abstract
Background: Menopause is associated with increased adiposity, especially increased deposition of intra-abdominal
(IA) adipose tissue (AT). This differs from common or ‘dietary’ obesity, i.e., obesity apparently due to
environmentally stimulated overeating, in which IAAT and subcutaneous (S) AT increase in similar proportions. The
effect of menopause on adiposity is thought to be due to the decreased secretion of ovarian estrogens.
Ovariectomy in rats and other animals is a commonly used model of menopause. It is well known that
ovariectomy increases adiposity and that this can be reversed by estradiol treatment, but whether ovariectomy
selectively increases IAAT has not been measured directly. Therefore, we used micro-computed tomography
(microCT) to investigate this question in both chow-fed and dietary-obese rats.
Methods: Ovariectomized, ovariectomized and estradiol treated, and sham-operated (intact) rats were fed chow or
chow plus Ensure (Abbott Nutrition; n = 7/group). Total (T) AT, IAAT and SAT were measured periodically by
microCT. Regional distribution of AT was expressed as IAAT as a percentage of TAT (%IAAT). Excesses in these
measures were calculated with respect to chow-fed intact rats to control for normal maturational changes.
Chemical analysis of fat was done in chow-fed intact and ovariectomized rats at study end. Data were analyzed by
t-tests and planned comparisons.
Results: Body mass, TAT, total fat mass, fat-free body mass, and %IAAT all increased in chow-fed intact rats during
the 41 d study. In chow-fed rats, ovariectomy increased excess body mass, TAT, fat mass, fat-free body mass, and SAT,
but had little effect on IAAT, in chow-fed rats, leading to a decrease in %IAAT. Ensure feeding markedly increased
SAT, IAAT and TAT and did not significantly affect %IAAT. Ovariectomy had similar effects in Ensure-fed rats as in
chow-fed rats, although less statistically reliable. Estradiol treatment prevented all the effects of ovariectomy.
Conclusions: Both ovariectomy in rats and menopause are associated with increased TAT. After ovariectomy, fat is
preferentially deposited as SAT and lean body mass increases, whereas after menopause fat is preferentially deposited
as IAAT and lean body mass decreases. These opposite effects of ovariectomy and menopause on regional AT
distribution and lean body mass indicate that ovariectomy in rats is not a homologous model of menopause-associated
changes in body composition that should be used with great caution in investigations of adiposity-related diseases.
Background
M e n o p a u s ei n c r e a s e st h er i s k so fan u m b e ro fd i s e a s e s
[1-3]. The abrupt and marked decrease in ovarian secre-
tion of estrogens that occurs around menopause [4] is
thought to be the main cause of these increases in health
risks. In many cases, such as osteoporosis and stroke,
increased risk appears to result from losses of direct
estrogenic actions on the target tissues [2,5]. In others,
such as type 2 diabetes mellitus and cardiovascular dis-
ease, however, decreased estrogen production also
appears to increase risk indirectly, by increasing adiposity
[2,6-9].
Body mass index (BMI, mass in kg/height in m
2), axial
computed tomography (CT) or magnetic-resonance ima-
ging (MRI) scans limited to one or a few levels are com-
monly used measures of adiposity. A growing literature,
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ciently precise to detect physiologically significant
changes in the amount and regional distribution of adi-
pose tissue (AT) [10-16]. The best available estimates of
t h ee f f e c to fm e n o p a u s eo nt o t a la d i p o s i t yc o m ef r o m
studies of whole-body imaging or dual-energy x-ray
absorptiometry (DEXA) scans. We are aware of six cross-
sectional studies of this type in which multiple-regression
analysis was used to isolate effects of menopause from
those of aging per se [17-22]. In these studies, menopause
increased body fat ~5-10% body mass. In terms of physi-
cal health, this is a substantial gain, as epidemiological
data indicate that in moderately obese women, the risk of
diabetes decreases 16% for each kilogram, or ~2% body
mass, lost [23].
The effect of menopause on adiposity in the studies
above did not appear to depend on premenopausal body
mass. This is interesting because it suggests that meno-
pause adds to other causes of increased adiposity, in parti-
cular to obesity related to the increased availability and
consumption of palatable, high energy-dense foods that is
thought to be the main impetus for the obesity epidemic
(i.e., “dietary obesity”) [24-27].
Obesity-related health risks depend on the site, as well
as the amount, of AT deposition. Intra-abdominal AT
(IAAT) is thought to be the most deleterious form of adip-
osity, and lower-body (or gluteo-femoral) subcutaneous
AT (SAT), the least deleterious [28-31]. Many epidemiolo-
gical studies indicate that increased waist circumference or
increased waist to hip-circumference ratio is associated
with increased disease risk [9,29,30,32]. Waist circumfer-
ence, however, does not distinguish abdominal SAT from
IAAT. This distinction requires direct measurements with
CT, MRI or other imaging techniques. The effect of meno-
pause on IAAT has been measured with whole-body ima-
ging and analyzed by multiple regression only once. In this
study, menopause increased IAAT by ~2 kg, from 4.3% of
TAT in premenopausal women to 8.8% in postmenopau-
sal women. In addition, this increase in IAAT was asso-
ciated with increased signs of cardio-metabolic health risk,
including fasting concentrations of plasma insulin, trigly-
cerides and the inflammation mediators C-reactive protein
and tissue plasminogen-activator antigen [21]. This is con-
sistent with several other menopause studies using less
direct measures of IAAT [3,33].
The most common model for studying the physiology
of menopause is ovariectomy, which has long been
known to increase body mass and adiposity in rats and
mice. In several studies in which whole-body fat content
was analyzed by chemical carcass analysis 4-8 wk after
ovariectomy in chow-fed rats, body masses increased by
means of ~35-60 g and body fat contents increased ~6-
20 g [34-40]. Similar effects have been reported in mice
[41,42]. The effect of ovariectomy on regional AT
deposition, however, has not been clearly established in
either rats or mice. Several groups have described
increases in the mass of one or a few resected AT
depots following ovariectomy [43-47], but none has
described the total of all depots. Others have reported
the total fat content of different body areas, but not of
the AT depots per se. For example, Ainslie et al. [48],
using DEXA, reported that ovariectomy increased
“abdominal” and “peripheral” fat gain ~11 g each The
landmarks distinguishing abdominal and peripheral,
h o w e v e r ,w e r en o tg i v e n ,a n d ,a sn o t e d ,a b d o m i n a l
DEXA does not distinguish abdominal SAT from IAAT.
Clegg et al. [36] estimated that ovariectomy increased
IAAT more than SAT, but did not measure AT depots
directly; rather, they resected SAT together with the
skin and then estimated IAAT as the fat contents of the
remaining carcass as measured by chemical analysis. In
view of the fragmentary data on the effects of ovariect-
omy on AT mass and distribution in rats, our goal here
was to provide an improved platform for the use of
ovariectomy as a rodent model of menopause in obesity
research. We used a combination of microCT and che-
mical carcass analysis to provide the first direct mea-
sures of the effects of ovariectomy on TAT, IAAT, SAT
and fat outside the TAT (non-TAT fat) in chow-fed
and, except for the chemical analysis, dietary-obese rats.
We hypothesized that ovariectomy would affect adipos-
ity in rats similarly to the effect of menopause in
women; that is, by increasing TAT and the relative
deposition of IAAT.
Methods
Animals
Female Long-Evans rats (bred from founders from
Charles River, Sulzfeld, Germany) were housed individu-
ally in cages with wood-chip bedding, in a colony room
with a 12:12 h light-dark cycle (lights off 1700 h) and an
ambient temperature of 20 - 22°C. Water and ground
chow were available ad libitum, except as indicated. At
study onset (d 0) animals weighed 200 - 270 g and were
~12 weeks old. All procedures were approved by the
Veterinary Office of the Canton Zurich.
Measurement of AT mass
SAT, IAAT and TAT masses were measured periodi-
cally by microCT (LCT 100, Aloka, Tokyo, Japan). Rats
were anesthetized with isoflurane and placed supine in
the machine, and serial 2 mm scans were done from the
anterior aspect of lumbar vertebra 1 to the posterior
aspect of lumbar vertebra 6 (L1-6). Aloka software esti-
mated the volumes of AT, bone, air and the remainder
on the basis of their different x-ray densities, and distin-
guished SAT and IAAT by detecting the abdominal
muscle layers. These data were converted to masses and
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masses as previously described and validated for male
rats [49,50]. Whole-body scans of 44 female rats weigh-
ing 270 - 412 g were done to generate regression formu-
lae to extrapolate L1-6 AT masses to whole-body AT
masses in females. The formulae were (data in g):
whole-body IAAT mass = 1.1 (L1-6 AT mass) + 1.5,
(r
2 = 0.99); whole-body SAT mass = 3.0 (L1-6 AT mass)
+7 . 1( r
2 = 0.91); and TAT mass = SAT mass + IAAT
mass. Data below are transformed to whole-body values.
Rats were assigned to one of 6 groups (n = 7 each),
roughly matched for body and TAT masses on the basis
of d 0 data.
Surgery and hormone treatment
On d 1, rats were food deprived ~6 h and pretreated with
5 mg/kg trimethoprim sc and 20 mg/kg sulfadoxine sc for
antibiotic prophylaxis, 50 μg/kg atropine sulfate sc, and
80 μg/kg acepromazine ip. About 20 min later, they were
anesthetized with 5 mg/kg xylazine and 50 mg/kg keta-
mine, both ip. Four groups were ovariectomized via a
4 cm midline laparotomy and two groups were sham oper-
ated by laparotomizing them and visualizing the ovaries.
Immediately after surgery, 5 mg/kg carprofen was sc
injected for analgesia. This was repeated on d 2 and 3, and
the antibiotic prophylaxis was repeated on d 2. Rats recov-
ered pre-surgical body masses within 24 h. Hormone
treatments began on d 5. Two groups of OVX rats
received sc injections of 2 μg1 7 b-estradiol-3-benzoate
(Sigma-Aldrich, Buchs, Switzerland; Cat # E8515) in
100 μl sesame oil (Sigma-Aldrich), and two ovariectomized
groups and the two sham operated groups received oil
alone. This was repeated every 4
th d thereafter. This estra-
diol regimen has been shown to elicit a near-physiological
pattern of plasma estradiol concentration and to be suffi-
cient to maintain normal food intake, spontaneous meal
patterns, body mass, and (with progesterone) lordotic
reflexes in ovariectomized rats [51].
Procedure
Beginning on d 5, three groups were offered Ensure (cho-
colate Ensure Plus, Abbott Nutrition, Baar, Switzerland;
1.5 kcal/ml [4.7 kcal/g solids], ~28% energy from soy oil
and ~57% from sugar) ad libitum in addition to chow,
leading to the final allocation of rats into the six groups
listed in Table 1. Ensure feeding rapidly leads to marked
dietary obesity in male rats [52]. Routine maintenance,
injections, body mass measurements, and vaginal cytology
sampling [53] were done daily between 0900 and 1000 h.
On d 0, 20, 27, 34, and 41, AT mass was measured by
microCT between 1300 and 1500 h. Blood samples were
mixed with EDTA, and plasma was separated and stored
at -20°C. Rats were euthanized by CO2 inhalation on d 42.
Carcasses of CH-Intact and CH-OVX rats were stored at -
20°C.
Chemical carcass analysis
Frozen carcasses of CH-Intact and CH-OVX rats were cut
in 3 mm slices, lyophilized (BenchTop 2K Freeze Dryer,
V i r T i s ,G a r d i n e r ,N Y ,U S A )t oac o n s t a n tm a s s ,a n d
homogenized in a blender. Fat content was analyzed in
duplicate ~2 g aliquots by automated petroleum ether
extraction (Soxtec Avanti 2050, Foss Tecator, Hamburg,
Germany). In addition, in order to determine the amount
of fat in rat AT, samples of inguinal, epididymal, mesen-
teric, omental and retroperitoneal AT from 3 male Long
Evans rats were resected, combined and subjected to che-
mical analysis in the same run as the female samples. The
CVs (mean ± SEM) of rat and AT analyses were 0.06 ±
0.05 and 0.05 ± 0.05, respectively. The recoveries of ~0.25
- 0.5 g sesame oil (Sigma) added to rat (n = 8) and AT
(n = 2) samples were 0.96 ± 0.02% and 0.98 ± 0.03%,
respectively, and data were corrected for this. We also
compared the chemical analysis data to calculations of fat
content from carcass water content, as described by Cox
et al. [54], i.e., percent fat = -1.28 * percent carcass water +
95.22. The two methods agreed well: chemical extraction
(g) = 0.92 * (Cox method) - 0.5, r
2 =0 . 9 2 ,S E E=4g ,
F (1, 11) = 131.4, P < 0.05).
Data analysis
Our design depended upon regular ovarian cycling in
the intact rats and hyperphagia and the development of
dietary obesity in the Ensure-fed rats. All intact rats dis-
played regular 4 or 5 d cycles and were included in the
analysis. One Ensure-fed rat gained substantially less
body mass (63 g) and TAT (21 g) than all the other
Ensure-fed rats (mass gain range, 95 - 244 g; TAT gain
range (46 - 107 g); body mass and TAT gains were sta-
tistical outliers (z-scores 2.34 and 2.14, P < 0.01 and <
0.016, respectively) as determined by the median-abso-
lute deviate method as described previously [50] and the
rat was excluded from the analysis. Data were analyzed
only on the days of CT scans. In addition to analyzing
and presenting the raw data, we also expressed them as
excesses and present them in this form. This was done
Table 1 Group designations
Endocrine status Diet
Chow Chow and
Ensure
Intact CH-Intact EN-Intact
Ovariectomized CH-OVX EN-OVX
Ovariectomized with estradiol
treatment
CH-OVX
+E2
EN-OVX+E2
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power, and to make the data more comparable to the
forms recommended for studies of human obesity [55].
Excess is the difference between the changes in test
groups minus the mean change in the CH-Intact control
group. Subtracting the change in the CH-Intact control
rats is necessary because chow-fed rats normally gain
appreciable amounts of body mass and AT throughout
adulthood; i.e., they are a dynamically changing control
[56]. To characterize this normal maturation, the d 0 -
d 41 differences in CH-Intact rats were analyzed with
t-tests. Because our focus in the main analysis was on a
small number of comparisons that included complex
comparisons, statistical power was maximized by analyz-
ing the data with planned comparisons. ANOVA was
done to generate an experiment-wide residual error,
which was used to compute standard errors of the dif-
ference (SED) and t-tests, the significances of which
were determined using the Hochberg variant of the
Bonferroni-Holm method [57], with an experiment-wide
two-tailed a-level of P < 0.05. Five comparisons were
tested: CH-OVX vs. CH-Intact, CH-OVX vs. CH-OVX
+E2, EN-Intact vs. CH-Intact, EN-OVX vs. EN-Intact,
and EN-OVX vs. EN-OVX+E2. Analysis of pilot data
indicated that with five comparisons, we would detect as
significant differences of ~10 g TAT, which we consider
biologically meaningful. The variability of data from the
Ensure-fed groups increased relatively faster than those
of chow-fed groups, necessitating square-root or loga-
rithmic transformation to achieve homogeneity of var-
iance. Chemical analysis data were analyzed by t-tests.
Data are reported as means ± standard errors of the
mean (SEM), and SED are given to indicate experiment-
wide residual errors.
Results
Effects of maturation and Ensure feeding
Body composition changed significantly in CH-Intact rats
during the 41 d study. Body mass increased 73 ± 6 g
(SED = 11 g, P < 0.001) and TAT, measured by microCT,
increased 15 ± 3 g (SED = 4 g, P < 0.01) (Table 2, top
row). SAT and IAAT increased in similar amounts (SAT,
7±2g ,S E D=3g ,P<0 . 0 3 ;I A A T ,8±1g ,S E D=2g ,
P < 0.01) (Table 3, top row), leading to an increase in
IAAT as a percentage TAT from 41 ± 1% to 46 ± 1%
IAAT (SED = 2%, P < 0.01) (Table 3). These dynamic
longitudinal changes in CH-Intact rats were used to cal-
culate changes in other groups in terms of excesses, as
described in the Data Analysis section.
Ensure-feeding led to marked dietary obesity. Body
mass, TAT mass, SAT mass and IAAT mass were signifi-
cantly increased in EN-Intact rats compared to CH-Intact
rats at study end, as shown in Tables 2 (levels of body
m a s sa n dT A T )a n d3( l e v e l so fS A Ta n dI A A T )a n d
Figures 1 (representative microCT images), 2 (excess
body mass and TAT; filled circles), and 3 (excess SAT
and IAAT; filled circles). The changes were progressive:
excess body mass and TAT mass were detected at each
measurement point and by d 41 reached levels of 64 ± 9
g (SED = 12 g, P < 0.05) excess body mass and 50 ± 5 g
(SED = 7 g, P < 0.05) excess TAT (Figure 2). Excess SAT
and IAAT were increased in EN-Intact rats on each test
day as well (e.g. d 41, excess SAT: 28 ± 3 g, SED = 5 g,
P<0 . 0 5 ;e x c e s sI A A T :2 3±2g ,S E D=3g ,P<0 . 0 5 )
(Figure 3). IAAT as a percentage TAT on d 41 was simi-
lar in EN-Intact rats and CH-Intact rats (46 ± 1 and 45 ±
1%, respectively, SED = 2%, n.s.) (Table 3).
Table 2 Body mass and TAT mass at study onset and end
BM (g) TAT (g)
d0 d4 1 d0 d4 1
CH-Intact 226 ± 6 298 ± 9
### 18 ± 1 33 ± 4
##
CH-OVX 226 ± 6 357 ± 10*
+ 19 ± 1 51 ± 2*
+
CH-OVX+E2 226 ± 7 281 ± 7 20 ± 1 34 ± 3
EN-Intact 226 ± 7 363 ± 7* 19 ± 1 84 ± 4*
EN-OVX 229 ± 7 399 ± 19
+j 18 ± 2 95 ± 10
EN-OVX+E2 233 ± 8 356 ± 14 20 ± 1 83 ± 7
Initial (d 0) and final (d 41) body mass (BM) and total adipose tissue (TAT)
mass, determined with microCT, of chow- and Ensure-fed intact rats (CH-Intact
and EN-Intact), ovariectomized rats (CH-OVX and EN-OVX), and estradiol-
treated ovariectomized rats (CH-OVX+E2 and EN-OVX+E2), means ± SEM.
Initial and final levels in CH-Intact rats were compared with t-tests to
characterize normal maturational changes. Group differences on d 41 were
analyzed by planned comparisons, with experiment-wide significance P <
0.05, as described in the text.
#Different from d 0, P < 0.05,
##P < 0.01,
###P < 0.001;
*Different from CH-Intact;
+OVX different from OVX+E2, same diet group;
jEN-OVX different from EN-Intact.
Table 3 SAT mass and IAAT mass at study onset and end
SAT (g) IAAT (g) IAAT (%)
d0 d4 1 d0 d4 1 d0 d4 1
CH-Intact 11 ± 0 18 ± 3
# 8±1 1 5±2
## 41 ± 1 46 ± 1
##
CH-OVX 12 ± 0 30 ± 1* 7 ± 0 20 ± 1* 38 ± 1 40 ± 1*
CH-OVX+E2 12 ± 0 19 ± 2 8 ± 1 16 ± 2 40 ± 1 45 ± 1
EN-Intact 12 ± 1 46 ± 3* 7 ± 1 38 ± 2* 38 ± 2 45 ± 1
EN-OVX 11 ± 1 54 ± 6 7 ± 1 41 ± 4 39 ± 4 43 ± 1
EN-OVX+E2 11 ± 1 44 ± 4 8 ± 1 39 ± 2 42 ± 2 47 ± 1
Initial (d 0) and final (d 41) levels (mean ± SEM) of subcutaneous adipose
tissue (SAT) and intra-abdominal adipose tissue (IAAT) masses of chow- and
Ensure-fed intact rats (CH-Intact and EN-Intact), ovariectomized rats (CH-OVX
and EN-OVX), and estradiol-treated ovariectomized rats (CH-OVX+E2 and EN-
OVX+E2). Regional adipose tissue distribution is expressed as percentage
IAAT/(SAT + IAAT). Initial and final levels in CH-Intact rats were compared with
t-tests to characterize normal maturational changes. Group differences on d
41 were analyzed by planned comparisons, with experiment-wide significance
P < 0.05, as described in the text.
*Different from CH-Intact;
#Different from d 0, P < 0.05,
##P < 0.01.
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Ovariectomy significantly increased body mass and TAT
mass levels in CH-Intact rats (Table 2). Significant
excesses in body mass were detected in CH-OVX rats
on each test day and significant excesses in TAT, on d
20 and subsequently (Figure 1 representative microCT
images, and Figure 2, open squares). On d 41, CH-OVX
rats had 58 ± 5 g excess body mass (SED = 12 g, P <
0.05) and 17 ± 2 g excess TAT (SED = 7 g, P < 0.05).
CH-OVX rats had significant excesses in SAT on d 21
and subsequently, but a significant amount of excess
IAAT only on d 34 (Figure 3, open squares). As a result,
IAAT as a percentage of TAT increased more slowly in
CH-OVX rats than in CH-Intact rats and was signifi-
cantly less on d 41 (40 ± 1% vs. 46 ± 1% in CH-OVX
and CH-Intact rats, respectively, SED = 2%, P < 0.05)
(Table 3). Finally, estradiol treatment significantly ame-
liorated all these effects of ovariectomy, except IAAT as
a percentage of TAT, which was 40 ± 1% in CH-OVX
rats and 45 ± 1% in CH-OVX+E2 rats (SED = 1%, n.s.),
(Tables 2 and 3; Figures 2 and 3, open triangles).
Chemical carcass analysis was used to further charac-
terize the effects of ovariectomy in chow-fed rats. At
study end, CH-OVX rats had ~56 g excess body mass
than CH-Intact rats (t (11) = 3.75, SED = 14 g, P <
0.01), which chemical analysis indicated was ~24 g fat
(t (11) = 4.37, SED = 5 g, P < 0.01) and, by subtrac-
tion, ~33 g fat-free body mass (t (11) = 2.63, SED = 12
g, P < 0.05) (Table 4; note body mass is not identical
to the values above because one rat’s sample was lost
from the chemical analysis). Chemical analysis of
resected AT samples indicated that AT contains 84 ±
1% fat (of wet mass), which agrees well with published
data [58,59]. This percentage was used to calculate the
fat content of AT measured by microCT. CH-OVX
rats had ~14 g more fat stored in the TAT at study
end (t (11) = 3.43, SED = 4 g, P < 0.05) and ~9 g
more fat stored outside the TAT (t (11) = 2.82, SED =
3 g, P < 0.05). Ovariectomy significantly changed body
composition: the amounts of body fat, fat in the TAT,
and fat outside the TAT normalized to fat-free body
mass were all significantly increased in CH-OVX rats
Figure 1 Representative microCT images. Representative microCT images showing SAT (yellow)a n dI A A T( magenta) at the level of lumbar
vertebra 6 on d 41 in chow-fed and Ensure-fed rats that were sham-operated (Intact), ovariectomized (OVX), or ovariectomized and estradiol-
treated (OVX+E2); white/gray is bone, black is air, and blue is the remainder.
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Page 5 of 12(t (11) = 3.68, SED = 0.018, P < 0.01; t (11) = 2.95,
SED = 0.013, P < 0.05; and t (11) = 2.63, SED = 0.011,
P < 0.05, respectively) (Table 4). The percentage of
total body fat stored in TAT, however, did not differ
significantly between CH-OVX and CH-Intact rats
(t (11) = 1.34, SED = 4%, P = 0.21).
Ovariectomy and estradiol treatment in Ensure-fed rats
Ovariectomy significantly increased body mass in
Ensure-fed rats, both in absolute terms (Table 2) and
expressed as excesses (Figure 2). TAT mass tended to
increase as well, but this was not statistically significant
(Figure 2; Table 2). Ovariectomy did, however, increase
excess SAT in EN-OVX rats in comparison to EN-Intact
rats on d 27 and 34 (9 ± 4 g and 11 ± 4 g, respectively,
SEDs = 3 g, Ps < 0.05) (Table 3, Figure 3). The differ-
ence on d 41 was similar, but not significant due to
increasing variability. Ovariectomy did not increase
excess IAAT in EN-OVX rats in comparison to EN-
Intact rats on any day; the resulting trend for a decrease
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Page 6 of 12in %IAAT, however, was not significant (on d 41, 43 ±
1% in EN-OVX rats and 45 ± 1% in EN-Intact rats, SED
= 2%, n.s.) (Table 3). Estradiol treatment significantly
ameliorated all the effects of ovariectomy that were
detected in Ensure-fed rats.
Although we did not include a planned comparison to
compare the effects of ovariectomy in the two diet groups
(i.e., excess in CH-OVX rats vs. the difference in excesses
between EN-OVX and EN-Intact rats), exploratory t-
tests suggested that ovariectomy did not differentially
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Figure 3 Effects of ovariectomy and estradiol treatment on excess SAT and IAAT. Excess SAT and excess IAAT were calculated with respect
to the chow-fed intact group (CH-Intact, y-axis = 0), as described in the text. The left panel shows chow-fed rats that were either ovariectomized
(CH-OVX; open squares) or ovariectomized and estradiol-treated (CH-OVX-E2; open triangles). The right panel shows Ensure-fed rats that were
sham operated (EN-Intact, filled circles), ovariectomized (EN-OVX, filled squares), or ovariectomized and estradiol-treated (EN-OVX-E2, filled
triangles). Data are means ± SEM and were analyzed by planned comparisons, with an experiment-wide significance of P < 0.05, as described in
the text. *different from CH-Intact;
ǂOVX different from OVX-E2, same diet group;
jEN-OVX different from EN-Intact.
Table 4 Body composition data at study end
BM FFBM Body fat TAT fat non-TAT fat
g g g /FFBM g /FFBM g /FFBM
Ch-Intact 301 ± 11 266 ± 7 37 ± 4 0.14 28 ± 4 0.10 9 ± 1 0.03
Ch-OVX 357 ± 10** 296 ± 9* 61 ± 3* 0.21** 42 ± 2** 0.14** 18 ± 3* 0.06*
Fat-free body (FFBM) and body-fat masses measured at study end (d 42) by chemical carcass analysis and partitioning of fat between the TAT and non-TAT
compartments of chow-fed intact (CH-Intact; n = 6) and ovariectomized rats (CH-OVX; n = 7). FFBM is body mass - body fat. Fat content of TAT was calculated
using the factor of 84% determined in the present study. Data (mean ± SEM) are absolute levels and, for fat data, are also normalized to FFBM. Data were
analyzed by t-tests.
*Different from CH-Intact, P < 0.05; **P < 0.01.
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Page 7 of 12affect either excess body mass (d 41, 58 ± 10 vs. 36 ± 19
g, t (12) = 1.04, SED = 22 g, P = 0.32) or excess TAT
(d 41, 17 ± 2 vs. 26 ± 10 g, t (12) = 0.63, SED = 10 g,
P = 0.54).
Discussion
It has been known for nearly a century that ovariectomy
increases adiposity in rats [60], and in recent years ovar-
iectomy has become the most prevalent model of the
increase in adiposity precipitated by menopause [61-64].
Nevertheless, many aspects of ovariectomy-induced obe-
sity have not been well characterized. Therefore, we
used microCT to determine directly for the first time
the effects of ovariectomy on the development of excess
AT and on regional AT distribution in chow-fed and
dietary-obese rats. In addition, we further characterized
the effects of ovariectomy effects on adiposity in chow-
fed rats with chemical analysis of body fat and tested
whether a physiological regimen of estradiol treatment
was sufficient to prevent the effects of ovariectomy.
Ovariectomy produced ~56 g excess body mass in ~6
wks in the chow-fed rats that were used for chemical
analysis. This consisted of ~33 g fat-free body mass and
~24 g fat. These data are similar to several previous
reports [35-38], although our effects are larger than
most, presumably due to the slightly longer study dura-
tion. Combining these data with the microCT data indi-
cated that ovariectomy led to ~17 g excess TAT, of
which ~14 g was fat and, consequently, ~9 g fat was
deposited outside the AT. We know of only a single
other report of the relative amounts of fat inside and out-
side the AT in rats: Tang et al. [56] found a similar effect
in lean and dietary-obese male rats, although they did
not emphasize this aspect of the data. Ovariectomy
increased relative adiposity as well as absolute adiposity:
n o r m a l i z e dt ot h ei n c r e a s ei nf a t - f r e eb o d ym a s s ,b o d y
fat, fat in the AT, and fat outside the AT all increased sig-
nificantly. The increases in absolute and relative adiposity
in rats appear to parallel studies in normal-weight
women revealing that menopause increases absolute and
relative adiposity independent of aging [17,18,20-22].
Use of microCT also enabled us to provide the first
direct measures of regional AT deposition in ovariecto-
mized rats. Based on the limited menopause data avail-
able [21], we hypothesized that ovariectomy would
increase IAAT relatively more than SAT. This hypothesis
was clearly disconfirmed. In chow-fed rats, ovariectomy
led to significant excess SAT (~12 g on d 41), but only
non-significant excess IAAT (~6 g). This resulted in a
significant reduction in the percentage of TAT deposited
as IAAT compared to CH-Intact rats (~40 vs. 46%). Simi-
larly, ovariectomy increased excess SAT clearly more
than it did excess IAAT in Ensure-fed rats. We pre-
viously demonstrated that our microCT technique
provides valid and accurate estimates of SAT and IAAT
in rats [49]. Therefore, we conclude that ovariectomy
leads to the deposition of more SAT than IAAT and,
depending on the diet, may not be associated with any
significant increases in IAAT. This is different from pre-
vious reports in rats that were based on less complete or
indirect measurements, e.g., resection of one or a few AT
depots [43-47] or DEXA of the abdominal regions [48],
which does not distinguish abdominal SAT from IAAT.
Clegg et al. [36] resected SAT and assumed that chemical
analysis of the remaining carcass reflected IAAT, i.e., that
there is little fat outside the AT. Our data indicate that
t h i si sn o tt h ec a s e ;i . e . ,w ef o u n dt h a to v a r i e c t o m y
i n c r e a s e dt h ef a tc o n t e n to ft h eI A A T~ 5ga n dt h ef a t
content outside IAAT ~10 g. We believe that this, per-
haps together with Clegg et al.’s rather small total ovar-
iectomy effect (increases of ~32 g body mass and only
~7 g body fat over 4 wk, vs. our increases of ~54 and ~24
g, respectively), accounts for the apparent difference in
results.
The selective effect of ovariectomy on SAT appears
different from the effect of menopause on regional adi-
pose tissue deposition, although the database is surpris-
ingly thin. There has been only one whole-body imaging
study with a statistical age control [21]. In this study,
menopause increased IAAT about twice as much as it
increased SAT. Several more limited imaging studies
have reported similar results [22,33,65,66], although
others have not found any selective increase in IAAT
[67,68]. Given that IAAT, especially truly visceral IAAT,
i.e., IAAT that drains into the hepatic-portal vein, poses
the more serious challenge to metabolic health [28-30],
these data suggest that the metabolic and cardiovascular
consequences of ovariectomy in rats may differ impor-
tantly from those produced by menopause-induced obe-
sity in women.
We also found that fat-free body mass increased ~33 g
in chow-fed ovariectomized rats. We assume that a sub-
stantial percent of this increase represent lean body mass,
as suggested by several previous reports in which lean
body mass was measured directly by chemical analysis
[37-40,69]. This effect is unlike menopause, which is
associated with a decrease in lean body mass [17,19,20].
The metabolic milieu associated with the marked
increases in lean body mass in rats vs. a loss of lean body
mass in women is likely to affect many of the same meta-
bolic variables that menopause-induced adiposity does.
This seems an important issue to consider in using ovar-
iectomy as a model of menopause, although we are una-
ware of studies that have done so. These different effects
of ovariectomy and menopause on lean body mass may
be due to differences in the effects of estrogens on
growth hormone and insulin-like growth factor I. This is
because ovariectomy increases and estradiol decreases
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menopause decreases and estrogen treatment increases
secretion of both [72-74]. It is not clear whether these
are species differences or are related to the difference in
relative age i.e., the ovariectomy data are from young
adult rats, whereas menopause occurs in middle age.
We included groups of Ensure-fed, “dietary-obese” rats
as a model of idiopathic human obesity, which is attrib-
uted in large part to overconsumption of palatable,
high-fat, high-sugar, energy-dense food [24-27]. As
expected, feeding intact rats Ensure led to further
increases in excess body mass (~65 g on d 41) and TAT
(~50 g). Ovariectomy led to further increases in body
mass (~35 g) and TAT mass (~12 g, which was not sig-
nificant). The smaller relative difference between body
mass and TAT mass produced by Ensure feeding com-
pared to the effects of ovariectomy in both chow- and
Ensure-fed rats suggests that the chronic positive energy
balances associated with ovariectomy and with dietary
obesity were partitioned into fat and lean tissue in quali-
tatively different fashions. We assume that dietary obe-
sity more closely mimics human obesity, in which there
is little or no gain of lean body mass.
The effects of Ensure feeding that we observed may be
to a certain extend diet-specific. This is because
Lemieux et al. [37] reported that ovariectomy produced
much larger effects on body mass and adiposity in rats
fed a 45% sucrose, 10% fat diet than in chow-fed rats,
whereas here the effects of ovariectomy were similar or
smaller in Ensure-fed rats than chow-fed rats. It is
i m p o r t a n tt on o t et h a tb o t hw ea n dL e m i e u xe ta l .[ 3 7 ]
began the dietary-obesity regimen only after ovariect-
omy, whereas women are more often obese before
menopause. A better model of dietary obesity and
menopause may be afforded by designs like that used by
Noel and Fleming [75], who made rats obese by force
feeding prior to ovariectomy. In this situation, ovariect-
omy produced similar amounts of excess body mass,
which was the only obesity measure, in obese and con-
trol rats (~40 and 45 g, respectively, at d 30).
Estradiol treatment significantly ameliorated the
effects of ovariectomy on the SAT, IAAT, TAT, and
body mass in both diet groups. The effects on total
adiposity and body mass are consistent with many pre-
vious studies [64], and the effects on SAT and IAAT
are novel. These results indicate that loss of estrogen
secretion is the crucial ovariectomy-induced lesion dis-
rupting normal energy homeostasis and causing
increased adiposity. That estradiol appeared to reduce
body mass below intact levels was unexpected here,
because this was not the case in several previous studies
using the same, near-physiological estradiol regimen
[36,51,76]. We have no explanation for this apparent
discrepancy.
The effects of estradiol treatment on adiposity that we
observed appear to parallel the effects of hormone repla-
cement therapy (HRT) in postmenopausal women. A
meta-analysis [77] of four studies [78-81] in which a total
of 129 postmenopausal women were randomly allocated
to HRT or to placebo or no treatment revealed that HRT
decreased abdominal body fat mass by ~7% and increased
lean body mass ~3%. In regard to abdominal SAT and
IAAT, however, both positive [66,81] and negative
[68,82] effects of HRT on IAAT have been reported in
studies in which part of the abdomen was imaged.
Furthermore, in two randomized trials [82,83] that not
included in the meta-analysis above, together involving
128 women, no effects of HRT on fat or fat-free mass
were detected. The different outcomes of these rando-
mized trials [78-83] may be related in part to the form of
HRT used. That is, HRT regimens involving larger
amounts of estrogens or smaller amounts of progestins
[80,81] tended to produce the larger effects. This is con-
sistent with rat studies, which indicate that the effects of
estradiol treatment on body mass in ovariectomized rats
is dose-dependent and can be reduced by pharmacologi-
cal progestin treatment [84].
Conclusions
Ovariectomy in rodents is a convenient model that
mimics the rapid decrease in plasma estrogens and the
increase in TAT associated with menopause. Rodent
ovariectomy, however, differs from menopause in two
ways that are likely to produce important differences in
metabolism and obesity-related pathophysiology. First, as
we report here, ovariectomy preferentially increases SAT
in rats, whereas menopause preferentially increases
IAAT, which is metabolically more deleterious. Second,
as our data suggest and others [37-40,69] have documen-
ted, ovariectomy induces gain of lean body mass, at least
in relatively young rats, whereas menopause induces loss
of lean body mass. These two opposite effects indicate
that rodent ovariectomy is a not a homologous model of
menopause-related changes in adiposity. Therefore, ovar-
iectomy should be used with great caution in investiga-
tions of adiposity-related disease.
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